10x Genomics, Inc. Share Price Target '$58.50', now 21.7% Upside Potential
10x Genomics, Inc. Share Price Target '$58.50', now 21.7% Upside Potential
Source: directorstalkinterviews.com
Chromium Single Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chromium Single Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chromium Single Cell Today - Breaking & Trending Today
10x Genomics, Inc. - Consensus 'buy' rating and 21.0% Upside Potential
10x Genomics, Inc. - Consensus 'buy' rating and 21.0% Upside Potential
Source: directorstalkinterviews.com
Beckman Coulter Life Sciences partners with 10x Genomics
Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation
Source: selectscience.net
10x Genomics, Inc. - Consensus 'buy' rating and 71.0% Upside Potential
10x Genomics, Inc. - Consensus 'buy' rating and 71.0% Upside Potential
Source: directorstalkinterviews.com
Beckman Coulter Life Sciences and 10x Genomics partner to enable single cell workflow automation
Beckman Coulter Life Sciences and 10x Genomics, Inc. today announced a new partnership to expand automation solutions for single cell assay workflows.
Source: news-medical.net